2005
DOI: 10.1200/jco.2005.06.237
|View full text |Cite
|
Sign up to set email alerts
|

Nonmelanoma Skin Cancer in Survivors of Childhood and Adolescent Cancer: A Report From the Childhood Cancer Survivor Study

Abstract: Long-term survivors of childhood and adolescent cancer who were treated with RT are at highest risk for developing NMSC. Educational efforts need to be directed to this population to facilitate early diagnosis of NMSC and reduction in sun exposure.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
104
0
4

Year Published

2006
2006
2023
2023

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 150 publications
(110 citation statements)
references
References 31 publications
2
104
0
4
Order By: Relevance
“…47 Although development of an NMSC within the RT field is a recognized risk, it portends increased tissue sensitivity to RT. Therefore, the decreased risk of overall mortality in cohort members who developed an NMSC was unexpected.…”
Section: Discussionmentioning
confidence: 99%
“…47 Although development of an NMSC within the RT field is a recognized risk, it portends increased tissue sensitivity to RT. Therefore, the decreased risk of overall mortality in cohort members who developed an NMSC was unexpected.…”
Section: Discussionmentioning
confidence: 99%
“…10 In addition, survivors treated with ionizing radiation are at increased risk for nonmelanoma skin cancers, leaving additional scarring or disfigurement. 3 Available data on the prevalence of these outcomes among adult childhood cancer survivors are limited. A small single-site study of dermatologic…”
Section: -9mentioning
confidence: 99%
“…Nonmalignant neoplasms, such as meningiomas, and nonmelanoma skin cancers are also ascertained in several cohort studies through the mechanisms described above (9,84,86). However, because these SPNs are not included in the population-based cancer registries, the SIR and the absolute excess risk (AER) for these outcomes cannot be determined.…”
Section: Subsequent Primary Neoplasmsmentioning
confidence: 99%